§ Funding Round
Series A funding round for DiogenX raising $37M in May 2023
Series A funding round for DiogenX raising $37M in May 2023
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
Advent France Biotechnology | — | — |
Boehringer Ingelheim | — | — |
Eli Lilly and Company | — | — |
Omnes Capital | — | — |
| Angel | david evans |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$42M
Top Valuation
-
DiogenX raised $37M in a Series A round.
The round was announced on 05/01/23.
